Nicole Murphy - 31 Mar 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Issuer symbol
BIIB
Transactions as of
31 Mar 2023
Net transactions value
-$32,251
Form type
4
Filing time
04 Apr 2023, 17:21:24 UTC
Previous filing
22 Feb 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +239 +4.3% $0.000000 5,818 31 Mar 2023 Direct F1
transaction BIIB Common Stock Tax liability $32,251 -116 -2% $278.03 5,702 31 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -239 -50% $0.000000 240 31 Mar 2023 Common Stock 239 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan.
F2 This award was granted to the reporting person on April 1, 2021. The remaining portion of the award vests in equal installments on each of the second and third anniversary of the grant date.